Trial NCT00547911

View at ClinicalTrials.gov 
Org. Study IDs: 080012
Secondary IDs: 08-N-0012

Last trial update was posted on 2014-07-17

MeSH Interventions

Carbidopa Droxidopa Entacapone

MeSH Conditions

Autonomic Nervous System Diseases Multiple System Atrophy Nervous System Diseases Parkinson Disease Primary Dysautonomias Shy-Drager Syndrome

Other Conditions


Stopping Reasons

Study terminated due to contamination droxidopa

Limitations And Caveats

Study was prematurely terminated due to a small amount of DOPAL contamination in the droxidopa. Because of the early termination only a small number of subjects were enrolled in each condition. Recently, the FDA has approved droxidopa.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID